ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. EVOK, CMND, TCRT, CDT, OGEN, SONN, GLTO, TTNP, SBFM, and JAGXShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Evoke Pharma (EVOK), Clearmind Medicine (CMND), Alaunos Therapeutics (TCRT), Conduit Pharmaceuticals (CDT), Oragenics (OGEN), Sonnet BioTherapeutics (SONN), Galecto (GLTO), Titan Pharmaceuticals (TTNP), Sunshine Biopharma (SBFM), and Jaguar Health (JAGX). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Evoke Pharma Clearmind Medicine Alaunos Therapeutics Conduit Pharmaceuticals Oragenics Sonnet BioTherapeutics Galecto Titan Pharmaceuticals Sunshine Biopharma Jaguar Health ASLAN Pharmaceuticals (NASDAQ:ASLN) and Evoke Pharma (NASDAQ:EVOK) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, community ranking, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk. Which has preferable valuation and earnings, ASLN or EVOK? Evoke Pharma has lower revenue, but higher earnings than ASLAN Pharmaceuticals. Evoke Pharma is trading at a lower price-to-earnings ratio than ASLAN Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Evoke Pharma$10.25M0.52-$7.79M-$2.87-1.24 Is ASLN or EVOK more profitable? ASLAN Pharmaceuticals has a net margin of 0.00% compared to Evoke Pharma's net margin of -71.32%. Evoke Pharma's return on equity of -308.49% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Evoke Pharma -71.32%-308.49%-53.66% Do institutionals and insiders hold more shares of ASLN or EVOK? 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are owned by insiders. Comparatively, 2.3% of Evoke Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer ASLN or EVOK? Evoke Pharma received 160 more outperform votes than ASLAN Pharmaceuticals when rated by MarketBeat users. However, 63.49% of users gave ASLAN Pharmaceuticals an outperform vote while only 57.69% of users gave Evoke Pharma an outperform vote. CompanyUnderperformOutperformASLAN PharmaceuticalsOutperform Votes20063.49% Underperform Votes11536.51% Evoke PharmaOutperform Votes36057.69% Underperform Votes26442.31% Does the media favor ASLN or EVOK? In the previous week, Evoke Pharma had 1 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 1 mentions for Evoke Pharma and 0 mentions for ASLAN Pharmaceuticals. ASLAN Pharmaceuticals' average media sentiment score of 0.00 equaled Evoke Pharma'saverage media sentiment score. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Evoke Pharma Neutral Which has more volatility & risk, ASLN or EVOK? ASLAN Pharmaceuticals has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Evoke Pharma has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. SummaryASLAN Pharmaceuticals and Evoke Pharma tied by winning 7 of the 14 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$6.51B$5.34B$8.44BDividend YieldN/A2.64%5.21%4.11%P/E Ratio-0.039.2026.9019.78Price / Sales0.10258.37389.48118.91Price / CashN/A65.8538.2534.62Price / Book-0.096.466.784.52Net Income-$44.22M$144.21M$3.23B$248.23M7 Day PerformanceN/A2.66%2.02%0.81%1 Month PerformanceN/A4.83%10.97%13.32%1 Year Performance-83.38%-2.54%17.38%7.69% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330EVOKEvoke Pharma0.1104 of 5 stars$3.24+0.6%N/A-36.3%$4.84M$10.25M-0.294Negative NewsGap UpCMNDClearmind Medicine0.1316 of 5 stars$1.04+5.1%N/A-16.7%$4.44MN/A-0.55N/ATCRTAlaunos Therapeutics1.1132 of 5 stars$2.69-5.3%N/A-76.3%$4.41M$10,000.000.0040Positive NewsEarnings ReportGap DownCDTConduit Pharmaceuticals0.7013 of 5 stars$0.38-2.6%N/A-99.9%$4.31MN/A-0.013News CoverageEarnings ReportStock SplitHigh Trading VolumeOGENOragenicsN/A$0.20-0.6%N/A-93.7%$4.27M$40,000.00-0.035SONNSonnet BioTherapeutics2.063 of 5 stars$1.31+1.6%$20.00+1,426.7%-27.3%$4.15M$1M0.0010GLTOGalecto1.6644 of 5 stars$3.07+6.6%$10.00+225.7%-80.9%$4.06MN/A-0.1640Gap DownTTNPTitan Pharmaceuticals0.619 of 5 stars$4.42-5.4%N/A-31.7%$4.04M$180,000.00-0.9610Analyst ForecastGap UpSBFMSunshine Biopharma1.8404 of 5 stars$1.49-0.7%$15.00+906.7%+76.3%$4.03M$34.87M-0.013Earnings ReportGap DownJAGXJaguar Health1.608 of 5 stars$5.76-2.0%$60.00+941.7%-98.0%$3.88M$11.69M0.0050Earnings ReportAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies EVOK Alternatives CMND Alternatives TCRT Alternatives CDT Alternatives OGEN Alternatives SONN Alternatives GLTO Alternatives TTNP Alternatives SBFM Alternatives JAGX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASLN Stock Free ASLN Stock Alerts